Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
48.26
-0.90 (-1.83%)
Official Closing Price
Updated: 7:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,507,572
Open
48.50
Bid (Size)
48.12 (200)
Ask (Size)
48.23 (500)
Prev. Close
49.16
Today's Range
48.03 - 48.91
52wk Range
45.05 - 112.52
Shares Outstanding
N/A
Dividend Yield
4.55%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market
↗
November 14, 2025
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn.
Via
Benzinga
Novo Nordisk Brings Back Former CEO To Lead Board
↗
November 14, 2025
Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.
Via
Stocktwits
Performance
YTD
-44.9%
-44.9%
1 Month
-14.0%
-14.0%
3 Month
-10.2%
-10.2%
6 Month
-28.0%
-28.0%
1 Year
-52.6%
-52.6%
More News
Read More
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Did Scholar Rock Soar 26% Today?
↗
November 14, 2025
Via
Stocktwits
Topics
Earnings
Ozempic Maker Novo Nordisk Faces Board Shakeup
↗
November 14, 2025
Via
Benzinga
Is It Too Late to Buy Novo Nordisk After the Drop?
↗
November 14, 2025
Via
The Motley Fool
Why Is Everyone Talking About Novo Nordisk Stock?
↗
November 14, 2025
Via
The Motley Fool
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO
↗
November 14, 2025
Via
Stocktwits
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
↗
November 13, 2025
Via
Stocktwits
Korro Bio Early Trial Results Fall Short; Stock Hits New Low
↗
November 13, 2025
Via
Benzinga
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report
↗
November 13, 2025
Via
Stocktwits
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
↗
November 13, 2025
Via
Benzinga
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs
↗
November 13, 2025
Via
Stocktwits
1 Incredible Reason to Buy LLY's Stock in November
↗
November 13, 2025
Via
The Motley Fool
Topics
Government
World Trade
Eli Lilly Soars: A Pharmaceutical Giant's Breakout Fueled by Blockbuster Drugs and Strategic Vision
November 12, 2025
Via
MarketMinute
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker
↗
November 12, 2025
Via
Benzinga
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch
↗
November 12, 2025
Via
Benzinga
Why Metsera's Share Price Is Plummeting This Week
↗
November 12, 2025
Via
The Motley Fool
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
↗
November 11, 2025
Via
Stocktwits
AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today
↗
November 11, 2025
Via
Benzinga
Topics
Stocks
Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India
↗
November 11, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 11, 2025
Via
Benzinga
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
↗
November 11, 2025
Via
The Motley Fool
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
November 10, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion
↗
November 10, 2025
Via
Investor's Business Daily
Topics
Initial Public Offering
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.26
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 11/14/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today